Sudarshan Chemical to acquire Germany-based Heubach Group

Sudarshan Chemical to acquire Germany-based Heubach Group


Sudarshan Chemical Industries has entered into a definitive agreement with the Germany-based Heubach Group, on its acquisition in a combination of an asset and share deal.

This strategic acquisition will create a global pigment company, combining SCIL’s operations and expertise with Heubach’s technological capabilities.

Click here to connect with us on WhatsApp

Post-acquisition, the combined company will have a broad pigment portfolio of high-quality products and a strong presence in major markets including Europe and the Americas. It will enhance SCIL’s product portfolio, giving it access to customers and a diversified asset footprint across 19 sites globally. The combined company will be led by Rajesh Rathi and a high performing management team with quality execution skills and technical competency.

 

The Heubach Group has a 200-year history and became the second largest pigment player in the world after its integration with Clariant in 2022. Heubach had over a billion euros in revenue in FY21 and FY22, with a global footprint especially in Europe, Americas, and the APAC region. The Group faced financial challenges over the past two years due to rising costs, inventory issues, and high interest rates. SCIL’s acquisition of Heubach will address these challenges with a clear turnaround plan.

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Oct 11 2024 | 7:14 PM IST



Source link

Sudarshan Chemical to acquire Germany-based Heubach Group

Indoco Remedies update on USFDA inspection of its facilities in Goa


Indoco Remedies has received regulatory status from U.S. Food and Drug Administration (USFDA), for its facilities located at Goa Plant-II & III, L-32,33,34, Verna Industrial Area, Verna, Goa, Goa 403722, India (Facility), following an inspection conducted by USFDA in July 2024.

The USFDA has determined that the inspection classification of this Facility remains as ‘Official Action Indicated’ (OAI).

Click here to connect with us on WhatsApp

The Facility had been inspected by the USFDA in February 2023 and had received an OAI status in May 2023.

Indoco is comprehensively working on the remedial action plan at the Facility which will be completed by Q3 2024.

 

Indoco had planned to inform USFDA for the inspection readiness post completion of the remedial action. However, USFDA had visited the Facility in July 2024, while the remedial action was still in progress. Hence, the compliance status of the Facility received as ‘OAI’ dated 10th October 2024, remains the same

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Oct 11 2024 | 7:10 PM IST



Source link

Sudarshan Chemical to acquire Germany-based Heubach Group

Hi-Tech Pipes successfully concludes QIP issue of Rs 500 cr


Hi-Tech Pipes announced the successful closure of Rs 500 crore Qualified Institutional Placement (QIP), with oversubscription by marquee institutional investors. The QIP, which opened on 07 October 2024 (post market hours) and closed on 11 October 2024, received bids of over Rs 800 crore. The overwhelming response from marquee qualified institutional investors, demonstrates strong confidence on the Company’s growth prospects.

The QIP attracted a diverse pool of top-tier institutional investors including mutual funds, and renowned foreign institutions and treasuries, reaffirming the market’s belief in Hi-Tech’s ability to navigate industry challenges and capitalise on the growing demand in the ERW (Electric Resistance Welding) steel tubes and pipes segment.

Click here to connect with us on WhatsApp

 

The QIP attracted leading domestic institutions like Motilal Oswal Fund, Bandhan Mutual Fund, Bank of India Mutual Fund, JM Financial Mutual Fund, LIC Mututal Fund, WhiteOak Mutual Fund, SBI General Insurance. Besides, prominent global institutions also participated in the QIP.

The Company issued 26,996,734 fresh equity shares @ ₹ 185.50 per equity share under QIP, representing a discount of 4.86% to the floor price and 7.39% discount to the last traded price on NSE on October 7, 2024.

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Oct 11 2024 | 7:07 PM IST



Source link

Markets decline for second consecutive week; Sensex ends 230 points lower

Markets decline for second consecutive week; Sensex ends 230 points lower



Benchmark indices fell on Friday as higher-than-expected US inflation muddled the outlook for rate cuts in the US. The Sensex ended the session at 81,381, with a decline of 230 points, or 0.3 per cent, while the Nifty50 index ended at 24,964, a drop of 34 points, or 0.14 per cent.


During the week, Sensex declined 0.4 per cent, and Nifty fell 0.2 per cent. Both indices posted their second consecutive weekly decline. In 2024 so far, Sensex has posted two consecutive weekly declines on four occasions and Nifty on three occasions. The last time both indices declined consecutively for two weeks was in August.

Click here to connect with us on WhatsApp

 


The core consumer price index in the US, which excludes food and energy costs, rose 0.3 per cent for a second month in September. And the three-month annualised rate advanced 3.1 per cent, the most since May. The US inflation figures present a pause in a string of recently released data that points towards moderating price pressures. It has rekindled debates about the magnitude of a rate cut by the Federal Reserve. Some analysts expect the Fed to go for a quarter-point cut in November but believe it won’t cut rates in its December meeting. The 10-year US bond yield rose 0.9 per cent and was trading at 4.09 per cent.


Concerns around corporate earnings growth plateauing for the quarter ended September further dented sentiment.


Tata Consultancy Services (TCS), India’s biggest IT services provider, reported a moderate performance on Thursday for the second quarter of FY25. Its net profit declined by 1.1 per cent. TCS’s stock fell by 1.8 per cent and was the worst-performing Sensex stock.


“Concerns of earnings downgrades in H2FY25 render Indian valuations difficult to sustain. However, the sustained flows into the domestic mutual funds, where monthly SIPs have set a new record of Rs 24,500 in September, will ensure that all FII selling will be easily absorbed by DII buying. This has been the trend in October so far,” said VK Vijayakumar, chief investment strategist, Geojit Financial Services.


Indian markets have been on a downward spiral amidst concerns of flows shifting to China and raging geopolitical tensions in West Asia. Going forward, the earnings are likely to determine the market trajectory.


“The market has been facing selling pressure on every rise, though resilience in key heavyweights has slowed the downward momentum. We recommend maintaining a cautious stance on the Nifty until it decisively surpasses the 20-day exponential moving average (DEMA), currently around the 25,300 level. With opportunities on both sides, traders should prioritise careful stock selection and effective trade management,” said Ajit Mishra, SVP, Research, Religare Broking.


The market breadth was positive with 2,143 stocks advancing and 1,751 declining. Half of the Sensex constituents declined. Apart from TCS, ICICI Bank, which fell 1.6 per cent, and HDFC Bank, which fell 0.7 per cent, were the biggest drag on Sensex. Metal stocks gained as investors are expecting China to deploy $283 billion in fresh stimulus to shore up its economy.

First Published: Oct 11 2024 | 6:53 PM IST



Source link

Sudarshan Chemical to acquire Germany-based Heubach Group

India's industrial production contracts 0.1% in August


India’s industrial production contracted 0.1 per cent in August, mainly due to poor showing by the mining and power generation sectors, according to official data released on Friday. The factory output, measured in terms of the Index of Industrial Production (IIP) witnessed a growth of 10.9 per cent in August 2023. The three major components of IIP, including mining, manufacturing and electricity, witnessed a contraction of 4.2 per cent, growth of 1 per cent and contraction of 3.7 per cent, respectively.

Powered by Capital Market – Live News

Click here to connect with us on WhatsApp

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Oct 11 2024 | 5:51 PM IST



Source link

Sebi intervenes in Rs 45 cr Trafiksol IPO irregularity on BSE SME platform

Sebi intervenes in Rs 45 cr Trafiksol IPO irregularity on BSE SME platform



The Securities and Exchange Board of India (Sebi) has intervened in the matter concerning alleged irregularities by Trafiksol ITS Technologies, which launched a Rs 45-crore initial public offering (IPO) on BSE’s small and medium enterprise (SME) platform last month.


In an ex-parte order, the market regulator has stated it will undertake a detailed examination into the disclosures made by the company in its draft offer document.

Click here to connect with us on WhatsApp


BSE halted the listing of Trafiksol, a software provider for traffic systems, amid complaints regarding the use of issue proceeds and wrongful disclosures.


Sebi’s probe is expected to be completed within a month.

 


Trafiksol’s IPO had garnered 345-times oversubscription.


In its offer document, the company had disclosed it would use Rs 17.7 crore for a software contract to a third-party vendor.


Sebi’s initial investigation revealed that the third-party vendor had not filed financial statements with the Ministry of Corporate Affairs for more than three years and had no revenue in the last year for which financials were filed. Additionally, the vendor’s financial statements for the previous three years were signed on the same day, just a few days before the listing. The vendor’s registered office was also closed, and its Goods and Services Tax (GST) return did not match the disclosed business activities.


“It cannot be ruled out at this stage that the attempt to award the software contract to a vendor, who prima facie appears to be a shell entity without any prior experience in developing a software platform of the nature disclosed by the company in its draft red herring prospectus (DRHP), was an attempt to deliberately mislead investors and divert the IPO proceeds,” noted Sebi whole-time member Ashwani Bhatia in the order.


Asserting the need for action, Sebi’s order notes that allowing such IPOs to list could shake the confidence of investors in the listed SME ecosystem. The regulator has also highlighted lapses by the merchant banker.


While investors have sought refunds of their investments, Sebi has directed BSE to ensure that the proceeds from the IPO are placed in an interest-bearing escrow account until further orders. The company will have no access to these funds.


The documents of SMEs for listing are not vetted by the market regulator; instead, the exchanges grant approval. The SME segment has gained traction with exorbitant listing gains, which have now been capped by the exchanges.


Amid rising instances of irregularities, Sebi is considering stringent measures to curb any misuse of the SME platform. A consultation paper on this matter is expected, according to sources.

First Published: Oct 11 2024 | 5:40 PM IST



Source link

YouTube
Instagram
WhatsApp